| 查看: 923 | 回复: 2 | ||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | ||
zhangju2014金虫 (正式写手)
|
[求助]
酮康唑（Ketoconazole）默克索引 已有1人参与
|
|
| 如题，求助，谢谢！ |
回复此楼» 猜你喜欢
海勃原辅料助力银屑病一线外用制剂开发
已经有0人回复
-
北京协和医学院杰青课题组招聘科研助理
已经有0人回复
-
药理学论文润色/翻译怎么收费?
已经有85人回复
-
求助https://www.pnas.org/doi/10.1073/pnas.2535777123 全文
已经有0人回复
-
二乙烯基砜的合成路径
已经有4人回复
-
求一株[b]敲除MTAP(human)的HCT-116(人结肠癌细胞)/b]细胞
已经有0人回复
-
求助！求美国食品化学药典内容：FCC13【低聚果糖专论】
已经有0人回复
-
【2027博士申请】纳米药物递送方向
已经有5人回复
-
消耗微量API，便可预测早期研发阶段的HME工艺可行性
已经有0人回复
-
反应液中苯酐除去
已经有1人回复
598878157
版主 (文学泰斗)
rky
- 应助: 369 (硕士)
- 贵宾: 3.087
- 金币: 103527
- 散金: 303
- 红花: 155
- 帖子: 58337
- 在线: 1153.4小时
- 虫号: 614840
- 注册: 2008-09-28
- 性别: GG
- 专业: 固体无机化学
- 管辖: 外语学习
3楼2017-06-29 17:54:14
mouse103
专家顾问 (著名写手)
- DRDEPI: 16
- 应助: 218 (大学生)
- 贵宾: 0.384
- 金币: 1423.7
- 散金: 2586
- 红花: 171
- 沙发: 1
- 帖子: 1626
- 在线: 411.4小时
- 虫号: 466716
- 注册: 2007-11-24
- 专业: 合成药物化学
- 管辖: 生物医药区
【答案】应助回帖
★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★
感谢参与，应助指数 +1
zhangju2014: 金币+30, ★★★★★最佳答案, 有溶解度信息吗？ 2017-06-29 17:46:20
感谢参与，应助指数 +1
zhangju2014: 金币+30, ★★★★★最佳答案, 有溶解度信息吗？ 2017-06-29 17:46:20
|
Title: Ketoconazole CAS Registry Number: 65277-42-1 CAS Name: cis-1-Acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine Manufacturers' Codes: R-41400 Trademarks: Fungarest (Janssen); Fungoral (Janssen); Ketoderm (Janssen); Ketoisdin (Isdin); Nizoral (Janssen); Orifungal M (Janssen); Panfungol (Esteve) Molecular Formula: C26H28Cl2N4O4 Molecular Weight: 531.43 Percent Composition: C 58.76%, H 5.31%, Cl 13.34%, N 10.54%, O 12.04% Literature References: Orally active, broad-spectrum antimycotic. Prepn: J. Heeres et al., DE 2804096, eidem, US 4144346 and US 4223036 (1978, 1979, 1980, all to Janssen); eidem, J. Med. Chem. 22, 1003 (1979). Pharmacokinetics: E. W. Gascoigne et al., Clin. Res. Rev. 1, 177 (1981); C. Brass et al., Antimicrob. Agents Chemother. 21, 151 (1982). HPLC determn in human serum: V. L. Pascucci et al., J. Pharm. Sci. 72, 1467 (1983). Series of articles on animal and human studies: Rev. Infect. Dis. 2, 519-692 (1980). Effect on hepatic enzymes in vitro and in vivo: K. N. Buchi et al., Biochem. Pharmacol. 35, 2845 (1986); J. K. Ritter, M. R. Franklin, Toxicol. Lett. 36, 51 (1987). Case reports of hepatic toxicity: J. K. Heiberg, E. Svejgaard, Br. Med. J. 283, 825 (1981); R. Rollman, L. Loof, Br. J. Dermatol. 108, 376 (1983). Controlled clinical trials: E. A. Petersen et al., Ann. Intern. Med. 93, 791 (1980); W. T. Hughes et al., J. Infect. Dis. 147, 1060 (1983); H. W. Jolly et al., Cutis 31, 208 (1983). Clinical evaluation as inhibitor of steroid synthesis: N. Sonino, N. Engl. J. Med. 317, 812 (1987). Review of pharmacology and therapeutic efficacy: C. A. Sohn, Clin. Pharm. 1, 217 (1982); R. C. Heel et al., Drugs 23, 1-36 (1982). Series of articles on clinical efficacy and therapeutic experience: Drugs Exp. Clin. Res. 12, 397-427 (1986). Properties: Crystals from 4-methyl-2-pentanone, mp 146°. LD50 in mice, rats, guinea pigs, dogs (mg/kg): 44, 86, 28, 49 i.v.; 702, 227, 202, 780 orally (Heel). Melting point: mp 146° Toxicity data: LD50 in mice, rats, guinea pigs, dogs (mg/kg): 44, 86, 28, 49 i.v.; 702, 227, 202, 780 orally (Heel) Therap-Cat: Antifungal. Keywords: Antifungal (Synthetic); Imidazoles. |
2楼2017-06-29 17:43:46
